Ostatní
Návod 
BioCryst Pharmaceuticals, Inc.
BCRX
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.5B
Obrat
1B
Zisk
0B
Aktiva
0B
Dluh
1B
ROE
2%
ROA
-2%
PE
8
PS
2
Cena 1R
6-11
⌀ Cena
8.23
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda
Profil
BioCryst Pharmaceuticals, Inc., biotechnologická společnost, objevuje nové, orální a malé molekuly léčiv. Společnost dodává peramivir injekce, intravenózní inhibitor neuraminidázy k léčbě akutní nekomplikované chřipky pod názvy RAPIVAB, RAPIACTA a PERAMIFLU, a ORLADEYO, perorální inhibitor serinové proteázy k léčbě dědičného angioedému. Vyvíjí se také BCX9930, perorální inhibitor faktoru D, který je v klinické studii fáze II u onemocnění zprostředkovaných komplementem; BCX9250, perorální inhibitor kinázy-2 podobný receptoru, který je v klinické studii fáze I k léčbě fibrodysplazie ossifikanů progressiva; a Galidesivir, polymerázový inhibitor závislý na RNA, který je v klinické studii fáze I k léčbě různých virů RNA, včetně Marburgu, žluté zimnice, eboly a ziky. Společnost spolupracuje a má licenční vztahy s Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; U.S. Department of Health and Human Services; a University of Alabama at Birmingham, stejně jako Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc Společnost byla založena v roce 1986 a sídlí v Durhamu v Severní Karolíně.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
580
Založení
1994-03-04
Podobné společnosti
$ 17.34
+ $ 0.88
$ 5.69
+ $ 0.10
$ 21.54
- $ 0.05
$ 9.89
+ $ 0.37
$ 11.08
+ $ 0.07
$ 7.35
- $ 0.51
$ 22.20
- $ 0.66
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 874.8 | 874.8 | 450.7 | 331.4 | 270.8 | 157.2 | 17.8 | 48.8 | 20.7 | 25.2 | 26.4 | 48.3 | 13.6 | 17.3 | 26.3 | 19.6 | 63.5 | |
| Cost of Revenues | 19.8 | 19.1 | 12.5 | 4.7 | 6.6 | 7.3 | 1.7 | 4.1 | 0.5 | 1.7 | 2.7 | 1.9 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | |
| Gross Profit | 855.0 | 855.8 | 438.2 | 326.8 | 264.2 | 149.9 | 16.1 | 44.7 | 20.2 | 23.5 | 23.7 | 46.4 | 13.5 | 17.2 | 26.2 | 19.6 | 63.4 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 406.6 | 159.4 | 163.4 | 145.5 | 131.5 | 117.1 | 109.3 | 92.8 | 93.4 | 86.7 | |
| Cost of Revenues | 9.9 | 2.5 | 2.8 | 4.6 | 6.1 | 3.2 | 1.7 | 1.3 | 2.1 | 1.1 | |
| Gross Profit | 396.6 | 156.9 | 160.6 | 141.0 | 125.4 | 113.9 | 107.6 | 91.5 | 91.3 | 85.6 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 216.6 | 253.3 | 208.8 | 123.0 | 107.1 | 84.9 | 67.0 | 61.0 | 72.8 | 51.8 | 42.7 | 51.5 | 56.9 | 82.5 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 213.9 | 159.4 | 118.8 | 67.9 | 37.1 | 29.5 | 13.9 | 11.3 | 13.0 | 7.5 | 5.2 | 6.8 | 12.3 | 14.2 | |
| Depreciation & Amortization | 5.0 | 1.4 | 1.2 | 1.7 | 5.1 | 0.1 | 9.4 | 1.9 | 0.8 | 0.7 | 0.5 | 0.2 | 0.2 | 0.3 | 0.6 | 0.9 | 2.3 | |
| Total Operating Expenses | 514.4 | 514.8 | 440.8 | 430.5 | 412.7 | 327.6 | 190.9 | 144.2 | 114.4 | 80.9 | 72.3 | 85.8 | 59.3 | 48.0 | 58.3 | 69.2 | 96.7 | |
| Operating Income | 341.0 | 341.0 | -2.5 | -103.7 | -148.4 | -177.7 | -174.8 | -99.5 | -94.2 | -57.4 | -48.6 | -39.4 | -45.8 | -30.7 | -33.9 | -49.6 | -33.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 69.6 | 46.9 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 64.4 | 50.6 | ||
| Depreciation & Amortization | 4.0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | ||
| Total Operating Expenses | 136.6 | 127.3 | 130.8 | 119.7 | 129.9 | 106.2 | 98.9 | 106.0 | 134.0 | 97.5 | ||
| Operating Income | 260.4 | 29.6 | 29.8 | 21.2 | -4.5 | 7.7 | 8.8 | -14.5 | -42.7 | -11.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 10.7 | 10.7 | 14.7 | 15.8 | 5.1 | 0.1 | 9.4 | 1.9 | 2.3 | 1.0 | 0.8 | 0.5 | 0.1 | 0.1 | 0.2 | 0.4 | 0.5 | |
| Interest Expense | 78.9 | 78.9 | 98.5 | 108.2 | 99.1 | 59.3 | 14.5 | 11.9 | 9.2 | 8.6 | 6.5 | 5.2 | 5.0 | 4.8 | 4.7 | 3.8 | 0.0 | |
| Other Expense | -73.6 | -73.6 | -84.4 | -122.5 | -95.9 | -4.1 | -8.1 | -9.4 | -0.1 | -0.8 | -0.8 | 1.1 | 5.5 | 5.3 | -2.5 | -4.0 | 503.5 | |
| IBT | 267.4 | 267.4 | -87.0 | -226.2 | -244.4 | -181.8 | -182.8 | -108.9 | -101.3 | -65.8 | -55.1 | -43.0 | -45.2 | -30.1 | -39.1 | -56.9 | -33,853.2 | |
| Income Tax Expense | 3.5 | 3.5 | 1.9 | 0.3 | 2.7 | 2.3 | 13.8 | 11.2 | 2.1 | 7.9 | 6.0 | 5.0 | 4.8 | 4.5 | 4.0 | 6.5 | 500.8 | |
| Net Income | 263.9 | 263.9 | -88.9 | -226.5 | -247.1 | -184.1 | -196.6 | -120.1 | -101.3 | -65.8 | -55.1 | -43.0 | -45.2 | -30.1 | -39.1 | -56.9 | -32.7 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 2.9 | 2.2 | 2.5 | 3.0 | 3.6 | 3.6 | 3.6 | 4.0 | 4.5 | 4.2 | ||
| Interest Expense | 14.1 | 19.7 | 21.6 | 23.5 | 24.4 | 24.8 | 24.7 | 24.5 | 24.6 | 27.3 | ||
| Other Expense | -12.4 | -17.5 | -23.3 | -20.5 | -21.5 | -21.1 | -21.3 | -20.5 | -20.5 | -23.9 | ||
| IBT | 248.0 | 12.1 | 6.5 | 0.8 | -26.0 | -13.4 | -12.5 | -35.0 | -63.2 | -35.8 | ||
| Income Tax Expense | 2.2 | -0.8 | 1.4 | 0.7 | 0.8 | 0.6 | 0.2 | 0.4 | -1.4 | 0.3 | ||
| Net Income | 245.8 | 12.9 | 5.1 | 0.0 | -26.8 | -14.0 | -12.7 | -35.4 | -61.7 | -36.1 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.18 | $-1.38 | $-1.03 | $-1.18 | $-1.04 | $-0.98 | $-0.78 | $-0.75 | $-0.59 | $-0.68 | $-0.55 | $-0.79 | $-1.26 | $-0.73 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.18 | $-1.38 | $-1.03 | $-1.18 | $-1.04 | $-0.98 | $-0.78 | $-0.75 | $-0.59 | $-0.68 | $-0.55 | $-0.79 | $-1.26 | $-0.73 | |
| Shares Outstanding | 211.0 | 209.9 | 206.7 | 192.2 | 179.1 | 179.1 | 167.3 | 115.6 | 103.2 | 84.5 | 73.7 | 72.9 | 66.8 | 55.2 | 49.5 | 45.1 | 44.6 | |
| Diluted Shares Outstanding | 219.3 | 218.6 | 206.7 | 192.2 | 179.1 | 179.1 | 167.3 | 115.6 | 103.2 | 84.5 | 73.7 | 72.9 | 66.8 | 55.2 | 49.5 | 45.1 | 44.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.31 | $-0.19 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.31 | $-0.19 | ||
| Shares Outstanding | 211.0 | 210.2 | 209.5 | 208.9 | 207.4 | 206.9 | 206.4 | 206.1 | 201.4 | 189.6 | ||
| Diluted Shares Outstanding | 219.3 | 219.9 | 219.9 | 215.3 | 207.4 | 206.9 | 206.4 | 206.1 | 201.4 | 189.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 80.2 | 104.9 | 110.6 | 304.8 | 504.4 | 272.1 | 114.2 | 26.7 | 50.3 | 22.1 | 28.9 | 54.5 | 21.2 | 20.9 | 16.4 | 13.6 | |
| Short Term Investments | 193.6 | 216.1 | 278.3 | 119.5 | 3.2 | 28.2 | 22.1 | 77.7 | 64.1 | 32.5 | 22.7 | 18.2 | 16.9 | 14.7 | 25.3 | 40.3 | |
| Total Cash & ST Investments | 273.8 | 321.1 | 389.0 | 442.4 | 514.4 | 300.4 | 136.2 | 126.8 | 155.7 | 63.6 | 99.2 | 113.9 | 40.6 | 36.8 | 41.7 | 53.9 | |
| Accounts Receivable | 68.8 | 79.1 | 57.0 | 50.6 | 29.4 | 8.6 | 22.1 | 4.3 | 6.1 | 8.8 | 6.2 | 9.5 | 2.1 | 4.6 | 5.8 | 31.3 | |
| Inventory | 4.5 | 8.1 | 28.7 | 27.5 | 15.8 | 7.0 | 1.6 | 1.6 | -37.8 | 0.5 | 1.6 | 0.7 | -2.4 | -0.4 | 0.3 | 0.9 | |
| Other Current Assets | 16.4 | 13.8 | 21.3 | 12.6 | 10.0 | 5.5 | 4.4 | 2.4 | 1.4 | 1.4 | 4.9 | 6.2 | 1.7 | 1.1 | 57.7 | 66.3 | |
| Total Current Assets | 363.5 | 422.0 | 496.0 | 516.5 | 566.1 | 323.8 | 164.3 | 114.4 | 125.4 | 67.0 | 66.0 | 89.3 | 42.1 | 42.0 | 63.6 | 97.7 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 84.1 | 88.0 | 105.5 | 104.9 | 97.7 | 78.4 | 84.3 | 112.4 | 150.9 | 146.2 | |
| Short Term Investments | 128.8 | 172.0 | 189.9 | 216.1 | 233.2 | 193.6 | 252.2 | 278.3 | 246.7 | 267.9 | |
| Total Cash & ST Investments | 212.9 | 260.0 | 295.4 | 321.1 | 330.8 | 272.0 | 336.6 | 390.8 | 397.6 | 414.1 | |
| Accounts Receivable | 91.3 | 91.2 | 93.4 | 79.1 | 72.5 | 68.8 | 60.6 | 57.0 | 53.6 | 57.7 | |
| Inventory | 5.2 | 5.0 | 6.9 | 8.1 | 7.6 | 4.5 | 29.8 | 28.7 | 29.6 | 27.0 | |
| Other Current Assets | 46.3 | 42.2 | 14.3 | 13.8 | 16.3 | 18.2 | 20.2 | 21.3 | 21.6 | 15.7 | |
| Total Current Assets | 355.7 | 398.5 | 410.0 | 422.0 | 427.1 | 363.5 | 447.1 | 496.0 | 397.6 | 414.1 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 20.1 | 19.8 | 20.9 | 15.4 | 8.7 | 7.1 | 7.3 | 9.1 | 9.5 | 9.9 | 5.1 | 0.2 | 0.3 | 0.6 | 1.1 | 1.9 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 64.3 | 21.7 | 0.0 | 18.1 | 6.8 | 0.0 | 0.0 | 22.4 | 41.3 | 8.9 | 47.7 | 41.1 | 2.6 | 1.2 | 15.4 | 11.8 | |
| Other Long-Term Assets | 24.5 | 26.9 | 0.1 | 0.0 | 6.5 | 3.8 | 3.6 | 1.0 | 2.0 | 4.0 | 5.7 | 6.2 | 3.9 | 13.7 | 2.2 | -0.8 | |
| Total Long-Term Assets | 109.0 | 68.5 | 21.0 | 33.5 | 22.0 | 10.9 | 10.9 | 32.5 | 52.9 | 22.9 | 58.6 | 47.5 | 6.7 | 15.5 | 18.7 | 12.9 | |
| Total Assets | 472.4 | 490.4 | 517.0 | 550.0 | 588.2 | 334.7 | 175.3 | 146.8 | 178.3 | 89.8 | 124.6 | 136.9 | 48.9 | 57.4 | 82.2 | 110.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 19.2 | 20.0 | 19.6 | 19.8 | 23.1 | 7.7 | 7.8 | 21.0 | 9.0 | 8.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 39.7 | 10.1 | 21.9 | 21.7 | 19.4 | 64.3 | 0.0 | 0.0 | 0.0 | 3.4 | |
| Other Long-Term Assets | 31.8 | 28.6 | 28.5 | 26.9 | 21.6 | 37.0 | 13.0 | 0.0 | 11.5 | 6.9 | |
| Total Long-Term Assets | 90.7 | 58.7 | 70.1 | 68.5 | 64.1 | 109.0 | 20.8 | 21.0 | 20.5 | 18.8 | |
| Total Assets | 446.4 | 457.2 | 480.0 | 490.4 | 491.3 | 472.4 | 467.9 | 517.0 | -685.5 | 529.9 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.8 | 11.6 | 20.9 | 14.4 | 27.8 | 18.7 | 14.0 | 7.8 | 6.3 | 4.3 | 9.3 | 2.8 | 4.2 | 4.0 | 2.5 | 8.2 | |
| Short-Term Debt | 31.7 | 35.4 | 2.6 | 2.4 | 1.8 | 31.2 | 40.0 | 33.7 | 35.2 | 28.2 | 30.0 | 30.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 89.6 | 113.3 | 126.4 | 87.6 | 72.7 | 55.6 | 36.3 | 27.7 | 24.8 | 19.8 | 23.0 | 17.8 | 9.6 | 11.9 | 14.0 | 17.1 | |
| Current Liabilities | 129.1 | 160.4 | 150.0 | 105.5 | 103.7 | 105.7 | 92.3 | 69.5 | 74.8 | 54.4 | 64.5 | 57.7 | 15.3 | 17.2 | 26.3 | 27.8 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 5.6 | 8.6 | 10.0 | 11.6 | 13.5 | 7.8 | 11.9 | 20.9 | 10.6 | 13.9 | |
| Short-Term Debt | 39.5 | 2.0 | 37.2 | 35.4 | 35.9 | 2.7 | 2.7 | 2.6 | 2.3 | 2.5 | |
| Other Current Liabilities | 145.2 | 166.6 | 92.6 | 113.3 | 104.2 | 118.6 | 105.3 | 126.4 | 77.4 | 75.3 | |
| Current Liabilities | 190.2 | 177.2 | 139.9 | 160.4 | 153.6 | 129.1 | 119.9 | 150.0 | 90.8 | 93.5 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 808.5 | 806.0 | 822.5 | 739.1 | 591.4 | 124.7 | 44.7 | 28.1 | 19.5 | 25.5 | 2.4 | 0.0 | 30.0 | 30.0 | 30.0 | 0.0 | |
| Capital Leases | 10.5 | 0.0 | 11.2 | 8.2 | 7.8 | 124.7 | 4.8 | 2.8 | 2.8 | 2.7 | 2.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.7 | -2.4 | 0.0 | 0.0 | 0.0 | -7.1 | 0.0 | |
| Total Liabilities | 948.0 | 966.4 | 972.5 | 844.6 | 695.1 | 354.0 | 137.0 | 97.6 | 94.5 | 88.3 | 76.8 | 61.2 | 50.0 | 57.9 | 67.4 | 43.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 643.6 | 701.2 | 792.1 | 806.0 | 806.3 | 819.0 | 824.1 | 822.5 | 843.1 | 825.1 | |
| Capital Leases | 12.0 | 12.5 | 0.0 | 0.0 | 0.0 | 13.2 | 13.8 | 11.2 | 10.0 | 5.8 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 834.3 | 878.8 | 932.0 | 966.4 | 959.8 | 948.0 | 944.1 | 972.5 | 933.9 | 918.6 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.1 | 2.1 | 2.1 | 1.9 | 1.8 | 1.8 | 1.5 | 1.1 | 1.0 | 0.7 | 0.7 | 0.7 | 0.6 | 0.5 | 0.5 | 0.4 | |
| Retained Earnings | -1,729.2 | -1,770.0 | -1,681.2 | -1,454.6 | -1,207.5 | -1,023.4 | -840.6 | -732.0 | -631.8 | -566.1 | -510.9 | -467.9 | -422.7 | -392.6 | -353.5 | -295.5 | |
| Comprehensive Income | 0.6 | 0.9 | 1.3 | 0.0 | 0.2 | 0.0 | 0.0 | -0.3 | -0.2 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Total Common Equity | -475.6 | -475.9 | -455.5 | -1,454.6 | -1,207.5 | -1,023.4 | -840.6 | -732.0 | 83.8 | 1.6 | 47.7 | 75.6 | -1.1 | -0.5 | 14.8 | 66.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | 1.9 | 1.9 | |
| Retained Earnings | -1,752.0 | -1,764.9 | -1,770.0 | -1,770.0 | -1,743.2 | -1,729.2 | -1,716.5 | -1,681.2 | -1,619.4 | -1,583.3 | |
| Comprehensive Income | 1.1 | 1.6 | 1.1 | 0.9 | 2.3 | 0.6 | 0.8 | 1.3 | 0.8 | 0.7 | |
| Total Common Equity | -387.9 | -421.6 | -451.9 | -475.9 | -468.6 | -475.6 | -476.2 | -455.5 | -1,619.4 | -1,583.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 850.6 | 841.4 | 848.7 | 741.5 | 593.2 | 124.7 | 84.7 | 61.8 | 54.7 | 53.7 | 32.4 | 30.0 | 30.0 | 30.0 | 30.0 | 0.0 | |
| Book Value | -475.6 | -475.9 | -455.5 | -294.6 | -107.0 | -19.3 | 38.3 | 49.2 | 83.8 | 1.6 | 47.7 | 75.6 | -1.1 | -0.5 | 14.8 | 66.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -387.9 | -421.6 | -451.9 | -475.9 | -468.6 | -475.6 | -476.2 | -455.5 | -1,619.4 | -1,583.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -145.9 | 263.9 | -88.9 | -226.5 | -247.1 | -184.1 | -182.8 | -108.9 | -101.3 | -65.8 | -55.1 | -43.0 | -45.2 | -30.1 | -39.1 | -56.9 | -33.9 | |
| Depreciation & Amortization | 1.5 | 1.4 | 1.2 | 1.7 | 1.4 | 0.8 | 0.7 | 0.7 | 0.8 | 0.7 | 0.5 | 0.2 | 0.2 | 0.3 | 0.6 | 0.9 | 2.3 | |
| Stock-Based Compensation | 55.6 | 0.0 | 65.4 | 55.6 | 44.7 | 34.6 | 14.8 | 17.7 | 9.4 | 12.6 | 8.5 | 9.7 | 10.2 | 4.4 | 4.2 | 4.8 | 6.3 | |
| Change Working Capital | -64.9 | -56.9 | -87.3 | -32.4 | -58.9 | 8.1 | 26.9 | -0.9 | -3.5 | 9.3 | -7.6 | 19.0 | 1.3 | 3.8 | -4.3 | 14.7 | -3.3 | |
| Change In Accounts Receivable | -11.2 | -36.8 | -22.7 | -6.1 | -21.5 | -23.8 | 18.5 | -16.2 | 0.6 | 2.7 | -2.5 | -7.4 | -7.4 | 2.4 | 1.3 | 25.0 | 9,424.9 | |
| Change In Accounts Payable | -52.5 | 57.8 | -62.4 | -16.8 | -22.4 | 39.4 | 17.4 | 11.7 | 4.5 | 3.8 | -10.5 | 6.8 | 6.8 | -2.0 | 2.1 | -10.7 | -9,431.0 | |
| Change In Inventories | -3.0 | -1.6 | -4.2 | -1.5 | -12.4 | -8.8 | -7.0 | 1.6 | -1.6 | 0.5 | 1.1 | -0.9 | -0.7 | -0.6 | 0.3 | 0.6 | 5.4 | |
| Other Non-cash Items | 118.8 | 121.5 | 57.5 | 106.5 | 98.1 | 54.2 | 2.4 | 1.3 | 0.9 | 0.9 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 4.0 | 0.0 | |
| Cash from Operations | -84.3 | 0.0 | 0.0 | -95.1 | -161.9 | -142.2 | -137.2 | -89.6 | -92.6 | -41.1 | -53.4 | -13.1 | -38.6 | -26.5 | -37.4 | -32.3 | -28.6 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 362.3 | 12.9 | 5.1 | 0.0 | -26.8 | -14.0 | -12.7 | -35.4 | -61.7 | -36.1 | |
| Depreciation & Amortization | 4.0 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | |
| Stock-Based Compensation | 72.6 | 0.0 | 21.3 | 21.4 | 21.3 | 17.2 | 13.2 | 13.7 | 16.5 | 12.3 | |
| Change Working Capital | 4.2 | -1.4 | 2.4 | -62.1 | -11.3 | -9.1 | -18.3 | -48.5 | 18.1 | -16.2 | |
| Change In Accounts Receivable | -15.5 | 0.0 | -7.3 | -14.0 | -7.3 | -3.3 | -8.2 | -3.8 | -3.0 | 3.8 | |
| Change In Accounts Payable | 35.4 | 24.6 | 45.0 | -47.1 | -2.4 | 0.0 | 0.0 | 0.0 | 19.9 | -15.3 | |
| Change In Inventories | -0.5 | -1.7 | 1.4 | -0.9 | -2.2 | -1.5 | 0.7 | -1.2 | 0.9 | -3.4 | |
| Other Non-cash Items | -167.1 | 29.2 | 12.2 | 12.9 | 11.3 | 13.9 | 16.1 | 16.3 | 17.3 | 32.5 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.9 | -19.9 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -1.9 | -2.5 | -1.1 | -2.2 | -1.4 | -2.4 | -0.5 | -0.3 | -0.4 | -0.3 | -5.3 | -5.1 | -0.1 | 0.0 | -0.1 | -0.1 | -0.3 | |
| Acquisitions | -18.7 | -6.2 | 0.0 | 0.0 | 1.4 | 2.4 | 0.5 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 324.8 | |
| Investments | -481.2 | -262.2 | -266.8 | -514.4 | -244.3 | -10.0 | -49.8 | -3.0 | -62.6 | -107.8 | -14.1 | -53.8 | -73.9 | -24.0 | -16.2 | -45.5 | -55.9 | |
| Sales of Investment | 504.1 | 256.6 | 320.5 | 385.1 | 117.4 | 28.2 | 43.5 | 81.3 | 67.7 | 43.5 | 42.7 | 42.4 | 34.0 | 20.3 | 40.8 | 56.9 | 56.5 | |
| Other Investing Activities | 21.6 | 0.0 | 0.0 | 0.0 | -1.4 | -2.4 | -0.5 | -0.4 | -0.4 | -1.7 | 0.1 | -1.5 | 0.0 | 0.2 | 0.3 | -0.1 | -324.8 | |
| Cash from Investing | 21.0 | 0.0 | 0.0 | -131.5 | -128.2 | 15.8 | -6.9 | 77.9 | 4.8 | -66.4 | 23.3 | -18.0 | -40.0 | -3.5 | 24.9 | 11.3 | 0.2 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.8 | -1.3 | -0.2 | -0.1 | -0.7 | -0.1 | -0.2 | -0.2 | -0.6 | -1.0 | |
| Acquisitions | -6.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.4 | -24.1 | |
| Investments | -125.5 | -58.6 | -29.3 | -48.8 | -39.5 | -26.9 | -112.3 | -88.0 | -157.0 | -123.9 | |
| Sales of Investment | 49.0 | 73.0 | 58.6 | 76.0 | 58.0 | 35.5 | 110.0 | 117.0 | 129.1 | 148.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 24.1 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -28.5 | 23.1 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -2.2 | 0.0 | 0.0 | 27.1 | 0.0 | 0.0 | -52.4 | 0.0 | -4.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 847.1 | 841.4 | -7.3 | 134.4 | 148.2 | 468.5 | 92.5 | 22.8 | 11.1 | 1.0 | 21.3 | 2.4 | 30.0 | 30.0 | 30.0 | 30.0 | 0.0 | |
| Issuance of Common Stock | 1.9 | 0.0 | 0.0 | 0.3 | 15.0 | 50.0 | 93.3 | 58.5 | 53.4 | 134.0 | 0.3 | 0.0 | 106.6 | 23.6 | 17.8 | 1.3 | 0.3 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -6.6 | 0.0 | 0.0 | 5.0 | 73.1 | 309.7 | 261.8 | 40.6 | 13.1 | 1.7 | 23.0 | 5.5 | 5.3 | 6.6 | -0.8 | 22.5 | 0.6 | |
| Cash from Financing | -4.6 | 0.0 | 0.0 | 32.5 | 88.0 | 359.7 | 302.7 | 99.1 | 62.5 | 135.7 | 23.3 | 5.5 | 111.9 | 30.3 | 17.0 | 23.8 | 0.8 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.2 | 0.0 | |
| Debt Issued | 683.1 | -20.1 | -126.1 | -12.1 | -0.7 | 20.5 | -5.2 | -21.8 | 839.9 | 4.2 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.0 | 1.2 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -3.2 | 1.2 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -67.6 | -103.3 | -6.1 | -193.8 | -201.5 | 233.4 | 158.6 | 87.4 | -25.3 | 28.2 | -6.8 | -25.6 | 33.4 | 0.3 | 4.4 | 2.8 | -27.5 | |
| Closing Cash Balance | 80.2 | 1.6 | 106.3 | 112.4 | 306.2 | 507.7 | 274.3 | 115.7 | 28.3 | 50.3 | 22.1 | 28.9 | 54.5 | 21.2 | 20.9 | 16.4 | 13.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -83.1 | -3.9 | -17.0 | 0.6 | 7.3 | 18.9 | -5.9 | -26.3 | -40.0 | 4.7 | |
| Closing Cash Balance | 1.6 | 84.7 | 89.9 | 106.9 | 106.3 | 99.1 | 80.2 | 86.1 | 112.4 | 152.5 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -86.2 | 327.4 | -53.1 | -97.3 | -163.2 | -144.5 | -137.7 | -89.9 | -92.9 | -41.5 | -58.7 | -18.2 | -38.7 | -26.6 | -37.5 | -32.3 | -28.9 | |
| Real Free Cash Flow | -141.8 | 327.4 | -118.6 | -152.9 | -207.9 | -179.2 | -152.5 | -107.6 | -102.3 | -54.1 | -67.2 | -27.9 | -48.8 | -30.9 | -41.7 | -37.1 | -35.2 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 275.2 | 39.8 | 41.1 | -27.7 | -5.9 | 8.2 | -1.5 | -53.9 | -9.5 | -20.9 | |
| Real Free Cash Flow | 202.7 | 39.8 | 19.8 | -49.0 | -27.2 | -9.1 | -14.7 | -67.6 | -26.0 | -33.2 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 8.1 | -15.6 | -1.4 |
| P/S | 2.4 | 18.3 | 9.4 |
| P/B | -5.5 | -1.9 | 5.2 |
| P/FCF | 10 | -12.9 | -1.5 |
| Market cap | $1.5 | $1.3 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 153 % | 57.6 % | 0 % |
| Debt to Income | 258.9 % | -289.7 % | 0 % |
| Debt to Free cash flow | 320.4 % | -218 % | 0 % |
| Interest expense percentage | 23.1 % | -17.6 % | 44.7 % |
| Current ratio | 1.9 | 2.8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -68 % | 42.2 % | 0 % |
| ROA | 59.1 % | -49.6 % | 0 % |
| CapEx to Revenue | 0.4 % | 1.8 % | 0 % |
| RaD to Revenue | 0 % | 227.3 % | 0 % |
| ROEM | 1,508,339.7 | 369714.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 97.3 % | 96.1 % | 68.7 % |
| Operating margin | 12.7 % | -203.4 % | 35.5 % |
| Net margin | -1.5 % | -224.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 219.9 mil | 113.2 mil |
| Employee count | 0.6 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
